Market Overview

Varian Will Acquire Embolic Bead Asset From Boston Scientific


Varian Medical Systems (NYSE: VAR) will acquire Boston Scientific’s (NYSE: BSX) portfolio of drug-loadable microsphere and bland embolic bead products. Terms of the transaction were not disclosed.

Boston Scientific’s portfolio of products treat arteriovenous malformations, which is a tangle of abnormal and poorly formed blood vessels and hypervascular tumors. Varian will not acquire any of the Boston Scientific operations, but plans to manufacture and distribute the products.

"This acquisition from Boston Scientific will strengthen Varian's growing position in the high-value interventional oncology segment and is consistent with our long-term strategy to become a global leader in multidisciplinary, integrated cancer solutions," said Dow Wilson, CEO of Varian.

Varian shares were trading down 0.30% at $139.20 Tuesday afternoon.

Related Links:

Karuna Therapeutics Opens Above IPO Price

ImmunoGen To Focus Operations On Mivetuximab Soravtansine Development

Posted-In: News Asset Sales


Related Articles (BSX + VAR)

View Comments and Join the Discussion!

The Next Wave Of Canadian Cannabis

Mid-Day Market Update: Crude Oil Down 3.5%; MDJM Shares Spike Higher